1. Home
  2. KNSL vs BIO Comparison

KNSL vs BIO Comparison

Compare KNSL & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kinsale Capital Group Inc.

KNSL

Kinsale Capital Group Inc.

HOLD

Current Price

$301.06

Market Cap

8.3B

Sector

Finance

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$244.99

Market Cap

6.9B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
KNSL
BIO
Founded
2009
1952
Country
United States
United States
Employees
N/A
7450
Industry
Property-Casualty Insurers
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.3B
6.9B
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
KNSL
BIO
Price
$301.06
$244.99
Analyst Decision
Hold
Buy
Analyst Count
11
4
Target Price
$403.45
$339.75
AVG Volume (30 Days)
300.5K
324.8K
Earning Date
04-23-2026
04-30-2026
Dividend Yield
0.30%
N/A
EPS Growth
21.77
N/A
EPS
4.88
N/A
Revenue
$1,873,987,000.00
N/A
Revenue This Year
$5.60
$2.74
Revenue Next Year
$7.88
$3.20
P/E Ratio
$62.08
$9.72
Revenue Growth
18.04
N/A
52 Week Low
$293.78
$211.43
52 Week High
$512.76
$343.12

Technical Indicators

Market Signals
Indicator
KNSL
BIO
Relative Strength Index (RSI) 30.60 32.08
Support Level N/A N/A
Resistance Level $364.61 $311.53
Average True Range (ATR) 12.20 9.73
MACD -1.91 -3.89
Stochastic Oscillator 15.87 13.00

Price Performance

Historical Comparison
KNSL
BIO

About KNSL Kinsale Capital Group Inc.

Kinsale Capital Group Inc is an insurance holding company. The company is engaged in offering property, casualty, and specialty insurance products. It offers specialty insurance products for allied health, healthcare, life sciences, professional, and a public entity. The company operates in only one reportable segment which is the Excess and Surplus Lines Insurance segment, which includes commercial excess and surplus lines liability and property insurance products through its underwriting divisions. The company generates revenues in the form of premiums and investment income.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: